EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Effect of dialysate buffer practices on serum parathyroid hormone concentrations in real-life french patients receiving hemodialysis

Pablo Antonio Ureña Torres iD, Moustafa Naja, Minh Hoang Tran, Martine Cohen-Solal, Jordi Bover, Anne Kolko, Pascal Seris, Ibrahim Farah, Natalia Alençar-de-Pinho iD, Ziad A Massy, Charles Chazot

PLOS One · 2026

DOI: 10.1371/journal.pone.0345776 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift PLOS One, 2026. Verfasst von Pablo Antonio Ureña Torres und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Dialysis, AURA Nord Saint-Ouen, Saint-Ouen, France. Hauptthemen laut MEDLINE: Parathyroid Hormone, Renal Dialysis, Dialysis Solutions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dialysate composition is crucial for managing secondary hyperparathyroidism (SHPT) in patients on hemodialysis. Acetate‐based dialysates elevate serum acetate and trigger adverse effects, while citrate and hydrochloric acid formulations might offer distinct clinical benefits.

Methods

In this longitudinal observational real-life study, 876 adult patients on hemodialysis were classified by acid component of the dialysate (acetic acid, citric acid, or hydrochloric acid). Monthly pre-dialysis parathyroid hormone (PTH) and bone-mineral biomarkers were measured. A linear mixed model (LMM), adjusted for baseline PTH, demographics, and clinical covariates, evaluated PTH trajectories over two years. The significance of the main effect of dialysate and its interaction with time was assessed using likelihood-ratio tests (LRT).

Results

At baseline, serum PTH was significantly higher in the acetate group. The LMM confirmed significant influence of dialysate type (p < 0.001) and its interaction with time (p = 0.048) on PTH trajectories. Over two years, acetate showed a modest, non-significant PTH reduction of 2.9% (95% CI: −8.8% to +3.4%), whereas hydrochloric acid resulted in a significant cumulative PTH reduction of 10.9% (95% CI: −15.7% to −0.2%), with a significantly different yearly slope versus acetate (p = 0.044). Citrate showed a modest, non-significant change compared to acetate (−2.3%; 95% CI: −6.7% to +8.4%). Baseline PTH, phosphate, prior hypercalcemia, and dialysate calcium concentration were major predictors in the model.

Conclusions

In adjusted longitudinal analyses, hydrochloric acid–based bicarbonate dialysate was associated with a steeper decline in pre-dialysis PTH over two years compared with acetate, while citrate did not differ from acetate. Prospective studies are needed to confirm whether buffer composition influences PTH control under standardized calcium-bath strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parathyroid HormoneRenal DialysisDialysis SolutionsHumansFemaleMaleMiddle AgedLongitudinal StudiesBuffersAgedFranceCitric AcidHyperparathyroidism, SecondaryHydrochloric Acid

Substanzen

Parathyroid HormoneBuffersCitric AcidDialysis SolutionsHydrochloric Acid

Autor:innen und Institutionen

  • Department of Nephrology and Dialysis, AURA Nord Saint-Ouen, Saint-Ouen, France.
  • Department of Renal Physiology, Necker Hospital, University of Paris Descartes, Paris, France.
  • AURA (Association pour l'Utilisation du rein Artificiel en Région Parisienne), Paris, France.
  • INSERM U1132 Université Paris-Cité and Department of Rheumatology, Lariboisière Hospital, Paris, France.
  • Department of Nephrology, University Hospital Germans Trias i Pujol (HGiTP), 8REMAR-IGTP Group, Research Institute Germans Trias i Pujol, Can Ruti Campus, Badalona (Barcelona), Catalonia, Spain.
  • Inserm Unit 1018, Team 5, CESP, Hôpital Paul Brousse, Paris-Saclay University (UPS) and Versailles Saint-Quentin-en-Yvelines University (UVSQ), Villejuif, France.

ORCID-Profile: Pablo Antonio Ureña Torres, Natalia Alençar-de-Pinho

Zitieren

APA

Ureña Torres, P. A., Naja, M., Tran, M. H., Cohen-Solal, M., Bover, J., Kolko, A., Seris, P., Farah, I., Alençar-de-Pinho, N., Massy, Z. A., & Chazot, C. (2026). Effect of dialysate buffer practices on serum parathyroid hormone concentrations in real-life french patients receiving hemodialysis. PLOS One. https://doi.org/10.1371/journal.pone.0345776

Vancouver

Ureña Torres PA, Naja M, Tran MH, Cohen-Solal M, Bover J, Kolko A, et al. Effect of dialysate buffer practices on serum parathyroid hormone concentrations in real-life french patients receiving hemodialysis. PLOS One. 2026. doi:10.1371/journal.pone.0345776

BibTeX
@article{UreaTorres2026,
  author = {Ureña Torres, Pablo Antonio and Naja, Moustafa and Tran, Minh Hoang and Cohen-Solal, Martine and Bover, Jordi and Kolko, Anne and Seris, Pascal and Farah, Ibrahim and Alençar-de-Pinho, Natalia and Massy, Ziad A and Chazot, Charles},
  title = {Effect of dialysate buffer practices on serum parathyroid hormone concentrations in real-life french patients receiving hemodialysis},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0345776}
}
Kostenlos starten →